Lataa...

Oncodriver inhibition and CD4(+) Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies

In patients with HER2-expressing breast cancer many develop resistance to HER2 targeted therapies. We show that high and intermediate HER2-expressing cancer cell lines are driven toward apoptosis and tumor senescence when treated with either CD4(+) Th1 cells, or Th1 cytokines TNF-α and IFN-γ, in a d...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Rosemblit, Cinthia, Datta, Jashodeep, Lowenfeld, Lea, Xu, Shuwen, Basu, Amrita, Kodumudi, Krithika, Wiener, Doris, Czerniecki, Brian J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2018
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5955413/
https://ncbi.nlm.nih.gov/pubmed/29796172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25208
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!